Page last updated: 2024-10-31

midodrine and Bladder, Underactive

midodrine has been researched along with Bladder, Underactive in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Research Excerpts

ExcerptRelevanceReference
"Pharmacological treatment options for underactive bladder (UAB) syndrome are limited."1.72Therapeutic effects of silodosin and urapidil on underactive bladder associated with diabetic cystopathy. ( Takeda, H; Tatemichi, S; Tezuka, M; Yonekubo-Awaka, S, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yonekubo-Awaka, S1
Tezuka, M1
Tatemichi, S1
Takeda, H1

Other Studies

1 other study available for midodrine and Bladder, Underactive

ArticleYear
Therapeutic effects of silodosin and urapidil on underactive bladder associated with diabetic cystopathy.
    Lower urinary tract symptoms, 2022, Volume: 14, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Diabetes Mellitus; Female; Midodrine; Rats; Strept

2022
chemdatabank.com